Displaying 901 - 920 of 1549
FTC Testifies on Antitrust Â鶹´«Ã½ in the Health Care Industry
FTC Requires Universal Health Services to Sell 15 Psychiatric Facilities as a Condition of Acquiring Rival Psychiatric Solutions
Promedica Health System, Inc.
Workshop Regarding Accountable Care Organizations and Implications Regarding Antitrust, Physican Self-Referral, Anti-Kickback and Civil Monetary Penalty (CMP) Laws
Novartis AG, In the Matter of (Alcon, Inc)
To settle FTC charges that its proposed acquisition of Alcon, Inc., would be anticompetitive, Novartis AG agreed to sell an injectable eye care drug used in cataract surgery. Novartis and Alcon are the only two U.S. providers of the class of drugs known as injectable miotics, and the FTC alleges that the acquisition would have created a monopoly in injectable miotics. The settlement requires Novartis to sell its drug Miochol-E to Bausch & Lomb, Inc.
FTC, HHS Â鶹´«Ã½, and Centers for Medicare & Medicaid Services Announce Workshop on Issues Related to Accountable Care Organizations
FTC Staff Opinion: Yakima Valley Memorial Hospital's Proposed Rx Program Exempt From the Robinson-Patman Act
Court Orders Internet Marketers of Acai Berry Weight-Loss Pills and "Colon Cleansers" to Stop Deceptive Advertising and Unfair Billing Practices
Carilion Clinic, a corporation, In the Matter of
The Commission issued an administrative complaint challenging Carilion Clinic’s 2008 acquisition of two competing outpatient clinics in the Roanoke, Virginia, area. The complaint alleges that Carilion’s acquisition of these outpatient centers eliminated competition for patients in the Roanoke area. On October 7, 2009 Carillion agreed to sell two independent outpatient medical clinics it acquired last year to settle the charges.
FTC Staff Opinion: Community CarePartners, Inc.'s Proposed Discount Rx Program Exempt From the Robinson-Patman Act
Minnesota Health Care Provider Group Settles FTC Price Fixing Charges
FTC Chairman Addresses American Medical Association
FTC Files Amicus Brief in Support of Rehearing of Ciprofloxacin "Pay-for-Delay" Case; FTC Approves Final Rule to Inform Consumers About Deposit Institutions That Lack Â鶹´«Ã½ Deposit Insurance
Arkansas Carpenters Health and Welfare Fund, et. al v. Bayer AG, et. al (In re Ciprofloxacin Hydrochloride Antitrust Litigation)
Statement by FTC Chairman Jon Leibowitz Regarding Todays Decision by the U.S. Court of Appeals for the Second Circuit in the Ciprofloxacin "Pay-for-Delay" Case
FTC Staff Opinion: University of Michigans Proposed Rx Program Exempt From Robinson-Patman Act
FTC Provides Comments to FCC on Protecting Children in Traditional and New Media Environments; FTC Approves Final Settlement Order Regarding The M Group, Inc., Doing Business As Bamboosa; FTC Approves Final Settlement Order Regarding Roaring Fork Valley
Displaying 901 - 920 of 1549